FABBRI, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 40.783
EU - Europa 16.999
AS - Asia 6.161
SA - Sud America 188
AF - Africa 97
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 35
Totale 64.304
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 40.635
GB - Regno Unito 6.892
IT - Italia 3.110
CN - Cina 2.192
SG - Singapore 1.836
SE - Svezia 1.823
DE - Germania 1.380
UA - Ucraina 1.331
TR - Turchia 1.006
FI - Finlandia 744
HK - Hong Kong 624
RU - Federazione Russa 531
BG - Bulgaria 494
FR - Francia 262
ID - Indonesia 179
IE - Irlanda 136
CA - Canada 113
BR - Brasile 110
IN - India 91
NL - Olanda 58
BE - Belgio 46
VN - Vietnam 46
RO - Romania 43
EU - Europa 36
IR - Iran 35
AU - Australia 32
JP - Giappone 26
MX - Messico 26
CL - Cile 24
IQ - Iraq 22
NG - Nigeria 22
MY - Malesia 21
CH - Svizzera 20
ES - Italia 20
ZA - Sudafrica 20
EG - Egitto 19
PL - Polonia 19
PK - Pakistan 16
TN - Tunisia 14
CO - Colombia 12
EC - Ecuador 12
LT - Lituania 12
KR - Corea 11
PE - Perù 11
SI - Slovenia 11
TH - Thailandia 10
AO - Angola 9
AR - Argentina 9
CZ - Repubblica Ceca 9
AL - Albania 8
AT - Austria 8
PT - Portogallo 7
BD - Bangladesh 6
TW - Taiwan 6
BO - Bolivia 5
HU - Ungheria 5
SY - Repubblica araba siriana 5
GR - Grecia 4
JO - Giordania 4
LV - Lettonia 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
CR - Costa Rica 3
MD - Moldavia 3
MW - Malawi 3
NO - Norvegia 3
NP - Nepal 3
NZ - Nuova Zelanda 3
SA - Arabia Saudita 3
UY - Uruguay 3
CV - Capo Verde 2
DK - Danimarca 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
LB - Libano 2
MA - Marocco 2
MG - Madagascar 2
MZ - Mozambico 2
OM - Oman 2
PA - Panama 2
AD - Andorra 1
AF - Afghanistan, Repubblica islamica di 1
AP - ???statistics.table.value.countryCode.AP??? 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CM - Camerun 1
DO - Repubblica Dominicana 1
GH - Ghana 1
HR - Croazia 1
KH - Cambogia 1
KW - Kuwait 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
Totale 64.296
Salva come PNG Salva come JPEG
Città #
Southend 6.009
Fairfield 5.791
Woodbridge 4.243
Jacksonville 3.079
Houston 3.057
Santa Clara 2.816
Ashburn 2.536
Chandler 2.260
Seattle 2.057
Dearborn 1.993
Wilmington 1.951
Cambridge 1.899
Ann Arbor 1.870
Singapore 1.380
Nyköping 900
Beijing 714
Modena 672
Hong Kong 610
San Diego 580
Princeton 556
Izmir 502
Sofia 494
Des Moines 488
Eugene 483
Helsinki 268
London 234
Milan 231
Moscow 199
Rome 185
New York 169
Dublin 135
Redwood City 117
Falls Church 116
Jakarta 98
Norwalk 95
Hefei 90
Boardman 81
Shanghai 81
Grafing 77
Nanjing 74
Palermo 62
Kunming 57
Guangzhou 51
Verona 46
Kilburn 45
Jinan 44
Brussels 42
Bari 39
Nanchang 35
Naples 35
Dallas 34
Florence 33
Bremen 32
Frankfurt am Main 32
Indiana 32
Los Angeles 32
Victoria 31
Dongguan 30
Hounslow 30
Bologna 28
Chiswick 28
Dong Ket 28
Wuhan 28
Saint Petersburg 27
Turin 26
Mountain View 24
Chicago 23
Philadelphia 23
San Mateo 23
Shenyang 23
Zhengzhou 23
Toronto 22
Mumbai 21
Chongqing 20
Hebei 20
Brescia 19
Catania 19
Chengdu 18
Ferrara 18
San Francisco 18
Ottawa 17
Auburn Hills 16
Fuzhou 16
Napoli 16
Phoenix 16
Parma 15
São Paulo 15
Warsaw 15
Siena 14
Hanoi 13
Munich 13
Prescot 13
San Giuliano Milanese 13
Timisoara 13
Belluno 12
Jinhua 12
Central District 11
Changsha 11
Lagos 11
Padova 11
Totale 50.684
Salva come PNG Salva come JPEG
Nome #
Medicina Interna Sistematica 1.632
Asma bronchiale 509
The Burden of Image Based Emphysema and Bronchiolitis in HIV-Infected Individuals on Antiretroviral Therapy 371
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 370
Clinical use of Levofloxacin in the long-term treatment of drug resistant tuberculosis. 328
Chronic Lung Disease in HIV Patients 252
La broncopneumopatia cronica ostruttiva nell'anziano 252
Use in routine clinical practice of two commercial blood tests for diagnosis of infection with Mycobacterium tuberculosis: a prospective study 245
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 236
Taking Aim at Asthma Around the World: Global Results of the Asthma Insight and Management Survey in the Asia-Pacific Region, Latin America, Europe, Canada, and the United States 235
Beclometasone–formoterol as maintenance and reliever treatment in patients with asthma: a double-blind, randomised controlled trial 226
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 225
Breakthroughs in internal and respiratory medicine 225
Cardiovascular mechanisms of death in severe COPD exacerbation: time to think and act beyond guidelines 224
Comparison of the tubercolin skin test and the ellispot blood test for the diagnosis of latent tuberculosis infection in pre-transplant dialysis patients 223
Insufficienza Respiratoria acuta e cronica (cap.21). 221
Effects of a walking aid in COPD patients receiving oxygen therapy 217
Eosinophilia in asthma: the easy way is not always the best 210
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 210
Prognostic role of clusterin in resected adenocarcinomas of the lung. 206
Exacerbation of respiratory Symptoms in COPD patients may not be exacerbations of COPD 204
Benralizumab: for asthma, not yet for COPD 203
Acute exacerbations of chronic obstructive pulmonary disease provide a unique opportunity to take care of patients 202
T cell-based tracking of multidrug resistant tuberculosis infection after brief exposure 200
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 199
Smoking, Not COPD, as the Disease 196
Tiotropium versus salmeterol for the prevention of exacerbations of COPD 195
Chronic critical illness: the price of survival 195
Use of adjunctive cardiovascular therapy in patients hospitalized for acute exacerbations of COPD. 195
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial 194
Roflumilast:un nuovo farmaco per il trattamento della BPCO 193
Inhaled Corticosteroids in COPD: Pros and Cons. 192
Home-centred physical fitness programme in morbidly obese individuals: a randomized controlled trial 190
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 189
Asthma in the elderly: what we know and what we have yet to know 189
Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents 188
Short-Term Efficacy of Upper-Extremity Exercise Training in Patients With Chronic Airway Obstruction: A Systematic Review. 188
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD 186
Triggering receptor expressed on myeloid cells: role in the diagnosis of lung infections 185
Insights, attitudes, and perceptions about asthma and its treatment: a multinational survey of patients from Europe and Canada 184
Airway inflammation in occupational asthma. 182
Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial 182
Cellular and structural bases of chronic obstructive pulmonary disease 180
Summary of recommendations for the design of clinical trials and the registration of drugs used in the treatment of asthma 180
T-cell-based diagnosis of neonatal multidrug-resistant latent tuberculosis infection. 180
Clusterin (CLU) and lung cancer. 180
Airway mucosal inflammation in occupational asthma induced by toluene diisocyanate 177
Changes in Your Breathing Can Change Your Brain 177
What is the origin of dyspnoea in smokers without airway disease ? 177
Effect of subchronic in vivo exposure to nitrogen dioxide on lung tissue inflammation, airway microvascular leakage, and in vitro bronchial muscle responsiveness in rats. 176
Link between chronic obstructive pulmonary disease and coronary artery disease: implication for clinical practice 175
Complex chronic co-morbidities of COPD 175
Quantiferon-TB Gold In-Tube Tests In Hospital Health Care Workers: A Five Years Experience 175
Systems medicine approaches for the definition of complex phenotypes in chronic diseases and ageing. From concept to implementation and policies 174
Sarcoidosis: challenging diagnostic aspects of an old disease. 174
The pharmacoepidemiology of COPD: recent advances and methodological discussion. 173
Chronic disease in the elderly: back to the future of internal medicine. 173
Short term efficacy of nebulized beclomethasone in mild-to-moderate wheezing episodes in pre-school children 173
Home Oxygen Saturation Monitoring And Quality Of Life Evaluation In Patients With Idiopathic Pulmonary Fibrosis: Preliminary Results From A Prospective Multicenter Trial 173
Chronic Obstructive Pulmonary Disease is just one component of the complex multimorbidities in patients with COPD. 172
Manuale Medico di Diagnostica e Terapia Roversi XI Edizione. (Editori: Renato Lauro, Francesco Rossi e Alberto Zanchetti; Revisore: Gianfranco Pagano) 171
Three-year hospitalization and mortality in elderly smokers with COPD or CHF. 171
Interleukin-13 and -4 expression in the central airways of smokers with chronic bronchitis 170
Identifying and Treating COPD in Cardiac Patients 169
Oxygen radical scavengers inhibit clastogenic activity induced by sonication of human serum. 169
Systemic effects of inhaled corticosteroids are milder in asthmatic patients than in normal subjects 169
Macrolides in the treatment of asthma and cystic fibrosis 168
Mechanisms of bradykinin-induced contraction in human fetal lung fibroblasts. 168
Mechanisms of acute exacerbation of respiratory symptoms in chronic obstructive pulmonary disease 168
Airway eosinophilia in chronic bronchitis during exacerbations. 167
Poor adherence to guidelines for long-term oxygen therapy (LTOT) in two Italian university hospitals. 167
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. 167
Energy expenditure at rest and during walking in patients with chronic respiratory failure: a prospective two-phase case-control study 166
Effect of bumetanide on toluene diisocyanate induced contractions in guinea pig airways. 166
Effect of antiasthma drugs on asthmatic reactions induced by toluene diisocyanate in sensitized subjects. 165
Intrapulmonary percussive ventilation in tracheostomized patients: A randomized controlled trial 165
Expression of protease activated receptor-2 (PAR-2) in central airways of smokers and non-smokers 165
Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice 165
How to Integrate Multiple Comorbidities in Guideline Development 164
Cytokines in the airway mucosa of subjects with asthma induced by toluene diisocyanate. 164
Reply: look at the moon, not just at the finger indicating the moon 164
Empoyment of the ELISPOT blood test for the diagnosis of latent tuberculosis infection in dialysis patients awaiting renal transplantation 164
Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa 163
The multiple components of COPD 163
An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease 162
Severe asthma in adults: what are the important questions? 162
Occupational asthma and extrinsic alveolitis due to isocyanates: current status and perspectives. 162
Respiratory muscles training in COPD patients 162
Ageing and multimorbidity 162
Beclomethasone/formoterol versus budesonide/formoterol combination therapy in asthma. 161
Pharmacological modulation of the contractile response to toluene diisocyanate in the rat isolated urinary bladder. 161
Identification of epithelial cells in bronchoalveolar lavage. 161
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 161
Detection of xanthine oxidase activity products by EPR and HPLC in bronchoalveolar lavage fluid from patients with chronic obstructive pulmonary disease. 161
Association between markers of emphysema and more severe chronic obstructive pulmonary disease 161
Similarities and discrepancies between exacerbations of asthma and chronic obstructive pulmonary disease. 161
Systemic Soluble Receptor for Advanced Glycation Endproducts Is a Biomarker of Emphysema and Associated with AGER Genetic Variants in Patients with Chronic Obstructive Pulmonary Disease 161
Mechanisms and pathology of occupational asthma. 160
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study 160
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD 160
Totale 20.588
Salva come PNG Salva come JPEG
Categoria #
all - tutte 274.506
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 274.506
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.858 0 0 0 0 0 2.001 2.540 1.252 1.237 426 783 619
2020/20218.929 821 358 828 716 1.096 657 799 1.284 265 1.140 499 466
2021/20228.366 186 1.276 963 673 216 357 636 409 851 561 1.330 908
2022/20236.892 803 496 362 556 845 1.260 116 733 1.035 118 316 252
2023/20244.221 176 311 297 440 772 440 423 530 148 122 143 419
2024/20256.069 611 264 175 868 2.559 1.592 0 0 0 0 0 0
Totale 64.774